Although there was a high number of successful pregnancy outcomes in patients with SPS and even more in SPS plus low-dose ASA therapy compared to patients without SPS or ASA therapy, it did not reach statistical significance.
← all excerpts
High Prevalence of Sticky Platelet Syndrome in Patients with Infertility and Pregnancy Loss.
3
—
—
The sentences
SPS patients with low-dose ASA therapy (a therapeutic inhibitor of platelet aggregation) ( n = 56) showed a trend to improved pregnancy outcome compared to SPS patients without low-dose ASA ( n = 13) (pregnant SPS patients n = 32, 57.1%, vs. pregnant non-SPS patients n = 3, 23.1%; live births n = 18, 56.3%, vs. n = 1, 33.3%) ( Table 5 ).
The only predictor with a highly significant odds ratio (12.6806) is the laboratory diagnostic presence of platelet hyperaggregability, clinically known as SPS in patients in our study cohort.